alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>



<ARTICLE>                 5
       
<S>                              <C>
<PERIOD-TYPE>                    6-MOS
<FISCAL-YEAR-END>                NOV-30-1998
<PERIOD-END>                     MAY-31-1998
<CASH>                           100,827
<SECURITIES>                     0
<RECEIVABLES>                    4,630,768
<ALLOWANCES>                     1,007,227
<INVENTORY>                      0
<CURRENT-ASSETS>                 4,017,651
<PP&E>                           1,012,444
<DEPRECIATION>                   638,254
<TOTAL-ASSETS>                   8,047,057
<CURRENT-LIABILITIES>            4,608,017
<BONDS>                          0
<COMMON>                         83,584
<PREFERRED-MANDATORY>            0
<PREFERRED>                      220,340
<OTHER-SE>                       1,395,974
<TOTAL-LIABILITY-AND-EQUITY>     8,047,057
<SALES>                          8,541,454
<TOTAL-REVENUES>                 8,541,454
<CGS>                            0
<TOTAL-COSTS>                    9,067,249
<OTHER-EXPENSES>                 0
<LOSS-PROVISION>                 0
<INTEREST-EXPENSE>               (160,534)
<INCOME-PRETAX>                  (816,329)
<INCOME-TAX>                     0
<INCOME-CONTINUING>              (816,329)
<DISCONTINUED>                   0
<EXTRAORDINARY>                  0
<CHANGES>                        0
<NET-INCOME>                     (816,329)
<EPS-PRIMARY>                    (.10)
<EPS-DILUTED>                    (.10)
        


</TABLE>
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER IN ACCORDANCE WITH SECTION 906 OF THE

                               SARBANES-OXLEY ACT


     In  conjunction  with the annual  report of Sharps  Compliance  Corp.  (the
"Company")  on Form 10-KSB for the years ended June 30, 2005 and 2004,  as filed
with the  Securities  and Exchange  Commission  on the date hereof,  I, David P.
Tusa, Senior Vice President and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge that

     (3)  The Form  10-KSB  report for the years  ended June 30,  2005 and 2004,
          filed with the  Securities  and Exchange  Commission  on September 14,
          2005,  fully complies with the requirements of Section 13 (a) or 15(d)
          of the Securities and Exchange Act of 1934; and

     (4)  The  information  contained  in the Form  10-KSB  report for the years
          ended  June  30,  2005  and  2004  fairly  presents,  in all  material
          respects,  the financial condition and results of operations of Sharps
          Compliance Corp.



      By:  /s/ DAVID P. TUSA


      David P. Tusa
      Executive Vice President
      Chief Financial Officer and
      Business Development



                                      F-23
Panel Members for the Meeting of the Federal Insecticide, Fungicide 

and Rodenticide Act Scientific Advisory Panel 

Scientific Conclusions Supporting EPA's FIFRA section 6(b) Notice of 

Intent to Cancel Twenty Homeowner Rodenticide Bait Products

November 29 - December 1, 2011

EPA-HQ-OPP-2011-0718 OPP Docket Tel: 703-305-5805

FIFRA SAP Chair

Kenneth Portier, Ph.D.

Program Director, Statistics and Evaluation Center

American Cancer Society

National Home Office

Atlanta, GA

Designated Federal Official

Joseph E. Bailey

US Environmental Protection Agency

Office of Science Coordination & Policy

FIFRA Scientific Advisory Panel

EPA East Building, (7201M)

1200 Pennsylvania Avenue, NW 

Washington, DC 20460

Tel: 202-564-8450, Fax: 202-564-8382, bailey.joseph@epa.gov

FIFRA Scientific Advisory Panel Members

Janice Chambers, Ph.D., DABT, ATS

William L. Giles Distinguished Professor

Director, Center for Environmental Health Sciences

College of Veterinary Medicine

Mississippi State University

Mississippi State, MS

Stephen Klaine, Ph.D.

Professor, Department of Biological Sciences

Director, Institute of Environmental Toxicology

Clemson University

Pendleton, SC

Martha Sandy, Ph.D.

Senior Toxicologist and Chief

Office of Environmental Health Hazard Assessment

California Environmental Protection Agency

Oakland, CA
Daniel Schlenk, Ph.D.

Professor, Aquatic Ecotoxicology and Environmental Toxicology 

Department of Environmental Sciences 

University of California, Riverside 

Riverside, CA

FQPA Science Review Board Members

A. Charles Crabb, Ph.D.

Consultant

Mudar Consulting

San Luis Obispo, CA

John E. Elliott, Ph.D.

Research Scientist, Ecotoxicology

Science & Technology Branch

Pacific Wildlife Research Centre

Environment Canada

Canada

Lisa A. Murphy, VMD, DABT

Assistant Professor of Toxicology

Department of Pathobiology

Toxicology Laboratory - New Bolton Center

University of Pennsylvania School of Veterinary Medicine

Kennett Square, PA

Michael Joseph Murphy, Ph.D., DVM

Veterinary Medical Officer

Center for Veterinary Medicine

Food and Drug Administration

Department of Health and Human Services

Rockville, MD

Maureen Murray, DVM, Dipl. ABVP 

Clinical Assistant Professor and Staff Veterinarian

Wildlife Clinic

Tufts University Cummings School of Veterinary Medicine

North Grafton, MA

William C. Pitt, Ph.D.

Field Station Leader

Hawaii Field Station

National Wildlife Research Center

USDA-APHIS

Hilo, HI
Barnett A. Rattner, Ph.D.

Ecotoxicologist and Supervisor

Patuxent Wildlife Research Center

U.S. Geological Survey

Department of the Interior

Beltsville, MD

John Greene Shepherd, PharmD

Clinical Professor and Director of Professional Education

University of North Carolina, Eshelman School of Pharmacy

Asheville, NC
#### § 218.100 Definition.

For purposes of this part the following definition shall apply: *Act* means the Securities Exchange Act of 1934 (15 U.S.C. 78a *et seq.*).
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Office of Science

# FOR FURTHER INFORMATION CONTACT:

Ms. Rachel Samuel at (202) 586-3279.

Issued in Washington, DC on October 1, 2009.

Eric Nicoll,

Committee Management Officer.

[FR Doc. E9-24024 Filed 10-5-09; 8:45 am]

BILLING CODE 6450-01-P
§ 1807.300 Eligible purposes. Each Recipient must use its CMF Award for the Eligible Uses described in § 1807.301 so long as such Eligible Uses increase private capital for and increase investment in: ( a ) Development, Preservation, Rehabilitation, and/or Purchase of Affordable Housing for primarily Extremely Low-Income, Very Low-Income, and Low-Income Families; and
( b ) Economic Development Activities, as further described in § 1807.403, which stabilize, sustain, or revitalize communities and neighborhoods and must be: located in a Low-Income Area or Underserved Rural Area; undertaken in conjunction with any affordable housing that is authorized as such under applicable local, State or Federal housing program laws, and reasonably available to, physically proximate to, and beneficial to residents of affordable housing.
Exhibit 99.1





CERTIFICATION PURSUANT TO


THE SARBANES-OXLEY ACT OF 2002





I, Anthony J. Cataldo, certify that:





1.  I have reviewed this annual report on Form 10-K/A (No. 2) of Calypte Biomedical Corporation;





2.  Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this annual report;





3.  Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of
the registrant as of, and for, the periods presented in this annual report;





Date: December 20, 2002





/s/    ANTHONY J.
CATALDO  Anthony J. Cataldo Executive Chairman
[Federal Register Volume 74, Number 193 (Wednesday, October 7, 2009)]
[Notices]
[Page 51613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, October 16, 2009, 8 a.m. to 
October 16, 2009, 5 p.m., Grand Hyatt Seattle, 721 Pine Street, 
Seattle, WA 98101 which was published in the Federal Register on 
September 22, 2009, 74 FR 48269-48273.
    The time of the meeting on October 16, 2009 has been changed to 
7:30 a.m. to 1:30 p.m. The meeting date and location remain the same. 
The meeting is closed to the public.

    Dated: September 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-24032 Filed 10-6-09; 8:45 am]
BILLING CODE 4140-01-M
Order entered May 6 , 2022

In The 

### Court of Appeals Fifth District of Texas at Dallas

No. 05

- 22

- 00069

- CV

RENESHA O. GRIFFIN , Appellant

V.

ESTELLE VILLAGE , Appellee

On Appeal from the County Court at Law No. 2

Dallas County, Texas Trial Court Cause No. CC

- 21

- 03882

- B

O RDER

T he clerk ’ s reco rd in this case is overdue. By postcard dated March 29
,
2022
, we notified the Dallas C oun ty C lerk that the clerk’s record was overd ue. We

direc ted the Dallas Co unty Clerk to file the clerk’s record within thirty days. To

date, the cler k’ s record has not been fil ed.

Ac cordingly, we ORDER the Dallas County Clerk to file, w i thin FIFTE EN

DAYS of the d ate of t his order, ei ther the clerk’s record or written verificat ion that
appellant ha s not paid for or m a de arrangem ents to pay for t he record and that s heis not entitled to proceed without payment of costs

. We not ify appellant that if we

receive verifi cation s he has not p aid for or made a r rangements to pay for the

r ecord and is not entitled to proceed without payment of costs, we will, without
further notice, dismiss the appe al. See T EX

. R. A PP

. P. 37.3(b).

We DIRECT the C l erk of the Cour t to send a co py of this ord er t o:

John Warren Da llas County Clerk
All parties

/s/ ROBERT D. BURNS, III CHIEF JUSTICE
<PAGE>

                                                                    Exhibit 10.7

                         Schedule of Omitted Documents

     Pursuant to Instruction No. 2 to Item 601 of Regulation S-K, MGM Grand,
Inc. has omitted from the Exhibits filed with its Current Report on Form 8-K the
First Security Bank Guarantee, which differs from the Firstar Bank of Minnesota
Guarantee filed as Exhibit 10.6 to this Current Report solely to the extent that
each guaranty supports a different agreement.  The signatory parties and
substantive text of both guarantees are exactly the same.  Only the parties in
whose favor the guarantees were executed and the recital stating the interest
rate and maturity date of the obligations being guaranteed are different, the
Firstar Bank of Minnesota Guarantee being in favor of Firstar Bank of Minnesota,
N.A. with respect to $250,000,000 of 7.25% Senior Notes due 2006 and the First
Security Bank Guarantee being in favor of First Security Bank, National
Association with respect to $200,000,000 of 6.75% Notes due August 1, 2007 and
$100,000,000 of 7.25% debentures due August 1, 2017.
#### § 1808.106 OMB control number.

The collection of information requirements in this part are subject to the review of the Office of Management and Budget (OMB).
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 99-50852 Summary Calendar

UNITED STATES OF AMERICA Plaintiff-Appellee,

versus JOSE OSCAR TRUJILLO-RAMIREZ, Defendant-Appellant.

-------------------- Appeals from the United States District Court for the Western District of Texas USDC No. DR-99-CR-348-1

-------------------- June 1, 2000 Before JOLLY, JONES, and BENAVIDES, Circuit Judges. PER CURIAM: * The Federal Public Defender appointed to represent Jose Oscar Trujillo-Ramirez has moved for leave to withdraw and has filed a brief as required by Anders v. California , 386 U.S. 738 (1967). Trujillo has received a copy of counsel’s motion and brief but has not filed a response. Our independent review of the brief and the record discloses no nonfrivolous issue for appeal. See id. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED.
[ARTICLE] 5
[LEGEND]
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS FOR SEPTEMBER 30, 1997 AS FILED ON FORM 10QSB WITH THE
SECURITIES EXCHANVE COMMISSION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
[/LEGEND]
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   9-MOS
[FISCAL-YEAR-END]                          DEC-31-1997
[PERIOD-END]                               SEP-30-1997
[CASH]                                         160,357
[SECURITIES]                                         0
[RECEIVABLES]                                  129,126
[ALLOWANCES]                                    12,000
[INVENTORY]                                    451,103
[CURRENT-ASSETS]                               769,088
[PP&E]                                         304,872
[DEPRECIATION]                                       0
[TOTAL-ASSETS]                               1,186,090
[CURRENT-LIABILITIES]                        1,545,338
[BONDS]                                              0
[PREFERRED-MANDATORY]                                0
[PREFERRED]                                          0
[COMMON]                                    12,913,693
[OTHER-SE]                                (13,272,941)
[TOTAL-LIABILITY-AND-EQUITY]                 1,186,090
[SALES]                                        731,977
[TOTAL-REVENUES]                               731,977
[CGS]                                          412,274
[TOTAL-COSTS]                                  412,274
[OTHER-EXPENSES]                             1,784,880
[LOSS-PROVISION]                                     0
[INTEREST-EXPENSE]                                   0
[INCOME-PRETAX]                            (1,391,355)
[INCOME-TAX]                               (1,391,355)
[INCOME-CONTINUING]                        (1,391,355)
[DISCONTINUED]                                       0
[EXTRAORDINARY]                                      0
[CHANGES]                                            0
[NET-INCOME]                               (1,391,355)
[EPS-PRIMARY]                                    (.49)
[EPS-DILUTED]                                    (.49)
</TABLE>
**EXHIBIT 31.1**
**CERTIFICATION**
     I, Paul A. Kruger, certify that:
1.  I have reviewed this quarterly report on Form 10-QSB of Boundless Motor Sports Racing, Inc. 2.  Based on my knowledge, this annual report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this quarterly report; 3.  Based on my knowledge, the financial statements, and other financial information included inthis annual report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the registrant as of, and for, the periods presented in thisannual report; 4.  The registrant’s other certifying officers and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this annual report is being prepared;
b) evaluated the effectiveness of the registrant’s disclosure controls and proceduresas of a date within 90 days prior to the filing date of this annual report (the“Evaluation Date”); and
c) presented in this annual report our conclusions about the effectiveness of thedisclosure controls and procedures based on our evaluation as of the Evaluation Date;
5.  The registrant’s other certifying officers and I have disclosed, based on our most recentevaluation, to the registrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal controls whichcould adversely affect the registrant’s ability to record, process, summarize andreport financial data and have identified for the registrant’s auditors any materialweaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal controls; and
6.  The registrant’s other certifying officers and I have indicated in this quarterly reportwhether or not there were significant changes in internal controls or in other factors thatcould significantly affect internal controls subsequent to the date of our most recentevaluation, including any corrective actions with regard to significant deficiencies andmaterial weaknesses.   Date: February 22, 2005 /s/ Paul A. Kruger   Paul A. Kruger, Chairman of the Board Chief Executive Officer and President
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

JACINTA I. GILLIS, )

DOC #R86811, )

)

Appellant, )

)

v. ) Case No. 2D15-5197

) 2D16-188

STATE OF FLORIDA, )

) CONSOLIDATED

Appellee. )

___________________________________)

Opinion filed June 5, 2019.

Appeal from the Circuit Court for Pinellas

County; Thane Covert, Judge.

Howard L. Dimmig, II, Public Defender, 

and Jeffrey Sullivan, Special Assistant 

Public Defender, Bartow, for Appellant.

Ashley Moody, Attorney General, 

Tallahassee, and Chelsea S. Alper, 

Assistant Attorney General, Tampa, for 

Appellee.

PER CURIAM.

Affirmed. 

NORTHCUTT, SILBERMAN, and ATKINSON, JJ., Concur.
**EXHIBIT 3.3**

 

CERTIFICATE OF AMENDMENT 

OF 

THE AMENDEDAND RESTATED 

CERTIFICATE OF INCORPORATION 

OF 

CALYPTE BIOMEDICAL CORPORATION 

 

CALYPTE BIOMEDICAL CORPORATION, a corporation organized andexisting under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: 

 

FIRST: That at a meeting of the Board of Directors of CALYPTE BIOMEDICAL CORPORATION, resolutions were duly adopted by unanimous writtenconsent dated January 8, 2003, setting forth a proposed amendment of the Amended and Restated Certificate of Incorporation of said corporation, declaring said amendment to be advisable and calling a meeting of the stockholders of said corporationfor consideration thereof. The resolution setting forth the proposed amendment is as follows: 

 

RESOLVED, that the Amended and Restated Certificate of Incorporation of this corporation be amended by changing the first paragraph of the Article thereof numbered “IV”, so that, as amended,said paragraph shall read as follows: 

 

“IV:

The corporation is authorized to issue two classes of shares of stock to be designated, respectively, Common Stock, $0.001par value, and Preferred Stock, $0.001 par value. The total number of shares that the corporation is authorized to issue is 805,000,000 shares. The number of shares of Common Stock authorized is 800,000,000 and the number of Preferred Stockauthorized is 5,000,000.” 

 

THIRD: That saidamendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware. 

 

FOURTH: That the capital of said corporation shall not be reduced under or by reason of said amendment. 

 

FIFTH: That said amendment shall become effective on February14, 2003. 

 

IN WITNESSWHEREOF, said CALYPTE BIOMEDICAL CORPORATION has caused this certificate to be signed by its President and Chief Executive Officer, this 14th day of February, 2003. 

 

  /s/     Nancy E. Katz

Nancy E. Katz

President and Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION FROM THE REGISTRANT'S
FINANCIAL STATEMENTS AS OF AND FOR THE NINE MONTH PERIOD ENDED OCTOBER 31, 2000,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JAN-31-2001
<PERIOD-START>                             FEB-01-2000
<PERIOD-END>                               OCT-31-2000
<CASH>                                       2,414,450
<SECURITIES>                                         0
<RECEIVABLES>                                5,698,395
<ALLOWANCES>                                   612,873
<INVENTORY>                                 42,104,932
<CURRENT-ASSETS>                            52,048,476
<PP&E>                                      44,242,746
<DEPRECIATION>                              26,632,521
<TOTAL-ASSETS>                              78,682,004
<CURRENT-LIABILITIES>                       45,226,415
<BONDS>                                      1,451,720
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        39,613
<OTHER-SE>                                  26,013,220
<TOTAL-LIABILITY-AND-EQUITY>                78,682,004
<SALES>                                    129,107,400
<TOTAL-REVENUES>                           129,107,400
<CGS>                                       82,688,541
<TOTAL-COSTS>                               82,688,541
<OTHER-EXPENSES>                            41,277,283
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,380,849
<INCOME-PRETAX>                              3,234,907
<INCOME-TAX>                                 1,261,000
<INCOME-CONTINUING>                          1,973,907
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,973,907
<EPS-BASIC>                                        .52
<EPS-DILUTED>                                      .46


</TABLE>